Jonathan Hoffmann
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
'Immune-response magnitude to tuberculosis infection tests and short-term disease risk' - Author's reply.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: August 31, 2026
Association between immune-response magnitude to tuberculosis infection tests and short-term disease risk: a prospective cohort study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 20, 2026
Association between immune response magnitude to tuberculosis infection tests and short-term disease risk: a prospective cohort study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 20, 2026
Molecular epidemiology of tuberculosis in Western Burkina Faso: insights from a MIRU-VNTR study.
Journal: BMC microbiology
Published: May 10, 2025
Perceptions of tuberculosis and home-based infection screening among families and providers in Madagascar: a qualitative study.
Journal: BMC public health
Published: January 20, 2025
Combination of exhaled breath condensate samples with lipoarabinomannan point of care assay for pulmonary tuberculosis (TB) diagnosis: protocol for a diagnostic accuracy study.
Journal: BMJ open
Published: September 16, 2024
Assessing the effects of diabetes mellitus on the monocyte-to-lymphocyte ratio and the QuantiFERON-TB gold plus assays for tuberculosis treatment monitoring: a prospective cohort study.
Journal: Frontiers in immunology
Published: June 18, 2024
Comparative Evaluation of Diagnostic Performance: Standard E TB Feron ELISA vs QuantiFERON-TB Gold Plus for Latent Tuberculosis Infection Detection in Diverse Risk Groups in Bangladesh.
Journal: Infection and drug resistance
Published: June 11, 2024
Xpert MTB/RIF Ultra for the rapid diagnosis of extrapulmonary tuberculosis in a clinical setting of high tuberculosis prevalence country and interpretation of 'trace' results.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: October 13, 2023
C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay.
Journal: Frontiers in immunology
Published: October 05, 2023
Opti-4TB: A protocol for a prospective cohort study evaluating the performance of new biomarkers for active tuberculosis outcome prediction.
Journal: Frontiers in medicine
Published: August 05, 2022
Last Updated: 09/26/2026